Concepedia

Author

Michael Wernecke

Acumen (United States)ORCID

Also Known As

M. Wernecke, MICHAEL WERNECKE, Michael Wernecke

88

Publications

2.9K

Citations

25

H-Index

25

Concepts

All Affiliations

Acumen (United States)Centers for Medicare and Medicaid ServicesStanford UniversityCenter for Biologics Evaluation and ResearchCenter for Drug Evaluation and Research
MW

About

Michael Wernecke is an author at Acumen (United States) specializing in medicine, epidemiology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

252

2

Public Health

4

4

222

3

Epidemiology

4

4

114

4

Health Policy

2

2

64

5

Emergency Medicine

1

1

138

Michael Wernecke

×

37

Publications

2.8K

Citations

25

H-Index

YearCitations

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke,

Circulation

2014

640

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke,

JAMA Internal Medicine

2016

319

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products

Cunlin Wang, David J. Graham, Robert C. Kane,

JAMA

2015

210

Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017–2018

Héctor S. Izurieta, Yoganand Chillarige, Jeffrey A. Kelman,

The Journal of Infectious Diseases

2018

162

Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation

David J. Graham, Elande Baro, Rongmei Zhang,

The American Journal of Medicine

2019

138

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure

Héctor S. Izurieta, Xiyuan Wu, Richard A. Forshee,

Clinical Infectious Diseases

2021

118

Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014

David K. Shay, Yoganand Chillarige, Jeffrey A. Kelman,

The Journal of Infectious Diseases

2017

106

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019

Héctor S. Izurieta, Yoganand Chillarige, Jeffrey A. Kelman,

The Journal of Infectious Diseases

2020

90

Comparative Effectiveness of Influenza Vaccines Among US Medicare Beneficiaries Ages 65 Years and Older During the 2019–2020 Season

Héctor S. Izurieta, Michael Lu, Jeffrey A. Kelman,

Clinical Infectious Diseases

2020

87

Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older

Héctor S. Izurieta, Michael Wernecke, Jeffrey A. Kelman,

Clinical Infectious Diseases

2016

78

Page 1